Capital Fund Management (CFM)’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $645K | Sell |
374,913
-224,958
| -38% | -$387K | ﹤0.01% | 794 |
|
|
2025
Q1 | $2M | Buy |
599,871
+409,688
| +215% | +$1.36M | 0.01% | 557 |
|
|
2024
Q4 | $1.41M | Sell |
190,183
-224,490
| -54% | -$1.66M | ﹤0.01% | 633 |
|
|
2024
Q3 | $3.89M | Buy |
414,673
+31,413
| +8% | +$295K | 0.01% | 399 |
|
|
2024
Q2 | $3.07M | Buy |
+383,260
| New | +$3.07M | 0.01% | 410 |
|
|
2023
Q4 | – | Sell |
-219,973
| Closed | -$1M | – | 901 |
|
|
2023
Q3 | $1M | Sell |
219,973
-52,657
| -19% | -$240K | ﹤0.01% | 529 |
|
|
2023
Q2 | $1.92M | Sell |
272,630
-162,616
| -37% | -$1.14M | 0.01% | 419 |
|
|
2023
Q1 | $2.66M | Sell |
435,246
-102,496
| -19% | -$626K | 0.01% | 328 |
|
|
2022
Q4 | $3.44M | Buy |
537,742
+437,434
| +436% | +$2.8M | 0.02% | 273 |
|
|
2022
Q3 | $961K | Buy |
+100,308
| New | +$961K | 0.01% | 426 |
|